FDA Terminates Emergency Use Authorization Of Hydroxychloroquine To Treat Covid-19

The Food and Drug Administration has canceled its emergency use authorization for the drugs hydroxychloroquine and chloroquine for the treatment of the coronavirus.

The FDA determined after reviewing the current research on the drugs that they do not meet “the statutory criteria” for emergency use authorization. And deemed the drugs unlikely to be effective in treating Covid-19 based on the latest scientific evidence, the agency noted on their website Monday morning.

“FDA has concluded that, based on this new information and other information discussed in the attached memorandum, it is no longer reasonable to believe that oral formulations of HCQ and CQ may be effective in treating COVID-19, nor is it reasonable to believe that the known and potential benefits of these products outweigh their known and potential risks,” FDA chief scientist Denise Hinton wrote in a letter to Gary Disbrow of the Biomedical Advanced Research and Development Authority (BARDA) on Monday.